---
figid: PMC5977110__cancers-10-00137-g005
figlink: /pmc/articles/PMC5977110/figure/cancers-10-00137-f005/
number: F5
caption: Schematic representation of the pharmacological compounds (black boxes) that
  inhibit YAP and TAZ oncogenic function through targeting YAP and TAZ or the main
  proteins and pathways that influence YAP and TAZ in lung cancer. Honokiol reactivates
  LKB1 and inhibits the YAP/TAZ/β-catenin oncogenic pathway. Statins and norcantharidin
  (NCTD) inhibit the mevalonate pathway and the production of monounsaturated fatty
  acids—two biosynthetic pathways of lipids that are increased in tumorigenesis. Through
  the inhibition of these two pathways, statins and norcantharidin inhibit oncogenic
  YAP, TAZ, and β-catenin signaling. Statins also inhibit EGFR autophosphorylation
  and β-catenin activation and nuclear translocation. Rottlerin is a natural polyphenolic
  compound which inhibits oncogenic TAZ in lung. EGFR inhibitors are too many to be
  listed here, but they inhibit the EGFR receptors and their downstream effectors
  and their inhibition has a synergistic effect when combined with YAP inhibition
  mediated by Verteporfin. This latter impairs the binding of YAP with the oncogenic
  transcription factors TEADs. Black arrows indicate pharmacological activation of
  the targeted proteins or pathways. Black blunt lines indicate pharmacological inhibition
  of the targeted proteins or pathways. As in previous figures, lines or arrows in
  red indicate signals which eventually activate nuclear YAP/TAZ, while lines or arrows
  in blue indicate signals or proteins which eventually inhibit nuclear YAP/TAZ, through
  mechanisms either dependent on or independent of Hippo pathway core kinases. Dashed
  arrows indicate reciprocal crosstalk between receptors and their downstream transduction.
pmcid: PMC5977110
papertitle: 'YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.'
reftext: Federica Lo Sardo, et al. Cancers (Basel). 2018 May;10(5):137.
pmc_ranked_result_index: '8579'
pathway_score: 0.9583084
filename: cancers-10-00137-g005.jpg
figtitle: Pathways that influence YAP and TAZ in lung cancer
year: '2018'
organisms: Homo sapiens
ndex: 65962d7f-dee1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5977110__cancers-10-00137-g005.html
  '@type': Dataset
  description: Schematic representation of the pharmacological compounds (black boxes)
    that inhibit YAP and TAZ oncogenic function through targeting YAP and TAZ or the
    main proteins and pathways that influence YAP and TAZ in lung cancer. Honokiol
    reactivates LKB1 and inhibits the YAP/TAZ/β-catenin oncogenic pathway. Statins
    and norcantharidin (NCTD) inhibit the mevalonate pathway and the production of
    monounsaturated fatty acids—two biosynthetic pathways of lipids that are increased
    in tumorigenesis. Through the inhibition of these two pathways, statins and norcantharidin
    inhibit oncogenic YAP, TAZ, and β-catenin signaling. Statins also inhibit EGFR
    autophosphorylation and β-catenin activation and nuclear translocation. Rottlerin
    is a natural polyphenolic compound which inhibits oncogenic TAZ in lung. EGFR
    inhibitors are too many to be listed here, but they inhibit the EGFR receptors
    and their downstream effectors and their inhibition has a synergistic effect when
    combined with YAP inhibition mediated by Verteporfin. This latter impairs the
    binding of YAP with the oncogenic transcription factors TEADs. Black arrows indicate
    pharmacological activation of the targeted proteins or pathways. Black blunt lines
    indicate pharmacological inhibition of the targeted proteins or pathways. As in
    previous figures, lines or arrows in red indicate signals which eventually activate
    nuclear YAP/TAZ, while lines or arrows in blue indicate signals or proteins which
    eventually inhibit nuclear YAP/TAZ, through mechanisms either dependent on or
    independent of Hippo pathway core kinases. Dashed arrows indicate reciprocal crosstalk
    between receptors and their downstream transduction.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STK3
  - MST1
  - WNT11
  - MTOR
  - ABL1
  - WNT16
  - WNT4
  - WNT1
  - RPTOR
  - TAZ
  - YY1AP1
  - PIK3R3
  - WNT2
  - AKT3
  - AKT1
  - AKT2
  - ABL2
  - WNT10B
  - WNT9B
  - WNT10A
  - WNT5B
  - WNT3A
  - YWHAQ
  - PIK3CG
  - WNT5A
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - CTNNB1
  - BTRC
  - EGF
  - EGFR
  - MAPK1
  - MAPK3
  - FZD10
  - WNT3
  - SGMS1
  - FZD5
  - ARAF
  - RAF1
  - BRAF
  - WNT8B
  - WNT2B
  - WNT9A
  - LATS1
  - LATS2
  - LPA
  - MAP2K1
  - MAP2K2
  - PIK3CD
  - HRAS
  - FZD3
  - FZD1
  - FZD4
  - PIK3R5
  - KRAS
  - NRAS
  - PIK3R6
  - FZD2
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - RASSF1
  - FZD6
  - FZD7
  - FZD8
  - NMUR1
  - FZD9
  - LPA
  - Honokiol
  - Statins
  - Rottlerin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MST1/2
  symbol: MST2
  source: hgnc_alias_symbol
  hgnc_symbol: STK3
  entrez: '6788'
- word: MST1/2
  symbol: MST1
  source: hgnc_symbol
  hgnc_symbol: MST1
  entrez: '4485'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ABL1
  symbol: ABL1
  source: hgnc_symbol
  hgnc_symbol: ABL1
  entrez: '25'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: YAP/TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
- word: YAP/TAZ
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ABL2
  symbol: ABL2
  source: hgnc_symbol
  hgnc_symbol: ABL2
  entrez: '27'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: BTRCP
  symbol: betaTrCP
  source: hgnc_alias_symbol
  hgnc_symbol: BTRC
  entrez: '8945'
- word: EGF,growth
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: MOB
  symbol: MOB
  source: hgnc_alias_symbol
  hgnc_symbol: SGMS1
  entrez: '259230'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Raf,
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf,
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf,
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: LATS1/2
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
- word: LATS1/2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Pi3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RASSF1
  symbol: RASSF1
  source: hgnc_symbol
  hgnc_symbol: RASSF1
  entrez: '11186'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
chemicals:
- word: LPA
  source: MESH
  identifier: C522988
- word: Honokiol
  source: MESH
  identifier: C005499
- word: Statins
  source: MESH
  identifier: D019821
- word: Rottlerin
  source: MESH
  identifier: C085746
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5977110__F5
redirect_from: /figures/PMC5977110__F5
figtype: Figure
---
